Trial intelligence / Profile preview

Photodynamic therapy with Metvix for acne: optimization of treatment number, light dose and pre-treatment

2014-005235-13Phase 4Completed

Sponsor
Sahlgrenska University Hospital
Start
Dec 2014
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of methyl aminolevulinate in acne vulgaris (2 arms), sponsored by Sahlgrenska University Hospital. Started Dec 2014; status: completed.

02

Drugs

methyl aminolevulinate
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on 2014-005235-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005235-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call